Table 2 Kaplan-Meier estimates of overall survival and cause-specific survival by histopathology
From: Prognostic value of histopathology and trends in cervical cancer: a SEER population study
Histology | ICDO 4-digits | n | 10 year overall survival (95% confidence interval) | 10 year cause-specific survival (95% confidence interval) |
|---|---|---|---|---|
All |  | 30989 | 57.8 (57.2–58.4) | 74.2 (73.7–74.8) |
Carcinoma not otherwise specified (NOS) | 8010 | 1688 | 71.1 (68.9–73.4) | 84.9 (83.1–86.7) |
Squamous cell carcinoma microinvasive | 8076 | 2910 | 90.6 (89.4–91.8) | 98.7 (98.2–99.1) |
Squamous cell carcinoma (SCC) |  | 20755 | 52.3 (51.5–53.0) | 69.7 (69.1–70.4) |
   SCC nonkeratinizing, NOS | 8072 | 2692 | 54.9 (52.9–57.0) | 69.1 (67.1–71.0) |
   SCC large cell, keratinizing | 8071 | 2373 | 54.4 (52.2–56.6) | 69.0 (66.9–71.1) |
   SCC NOS | 8070 | 15690 | 51.6 (50.7–52.4) | 70.0 (69.2–70.8) |
Adenosquamous carcinoma | 8560 | 1120 | 50.7 (47.5–53.9) | 66.6 (63.5–69.7) |
Adenocarcinoma excluding mucinous |  | 4015 | 60.9 (59.2–62.6) | 77.9 (76.4–79.3) |
   Endometrioid carcinoma | 8380 | 198 | 68.9 (59.9–78.0) | 87.9 (80.7–95.1) |
   Adenocarcinoma NOS | 8140 | 3302 | 61.5 (59.7–63.4) | 77.3 (75.7–79.0) |
   Papillary adenocarcinoma, NOS | 8260 | 348 | 58.9 (53.4–64.4) | 81.9 (77.3–86.4) |
   Clear cell adenocarcinoma, NOS | 8310 | 167 | 47.1 (38.6–55.5) | 68.2 (59.9–76.4) |
Mucinous adenocarcinoma |  | 305 | 43.0 (36.5–49.5) | 62.1 (55.4–68.8) |
   Mucous adenocarcinoma | 8480 | 181 | 43.6 (34.2–53.1) | 64.1 (54.7–73.6) |
   Mucin-secreting adenocarcinoma | 8481 | 124 | 41.3 (32.1–50.5) | 59.1 (49.2–68.9) |
Small cell carcinoma NOS | 8041 | 196 | 31.6 (24.5–38.8) | 44.5 (36.7–52.4) |